HALOZYME THERAPEUTICS, INC. - COM (HALO)

Q3 2024 13F Holders as of 9/30/2024

Type / Class
Equity / COM
Number of holders
500
Total Shares
124M
Shares change
+2.01M
Total reported value, excl. options
$7.08B
Value change
+$128M
Put/Call ratio
0.61
Number of buys
259
Number of sells
-198
Price
$57.24
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.